NeuroNews

The U.S. Food and Drug Administration today issued a supplemental approval for Casgevy (exagamglogene autotemcel) for patients aged 2 years and older with either sickle cell disease (SCD) with…

In a cross-sectional analysis of more than 1700 participants, plasma CGRP concentrations did not distinguish individuals with migraine from healthy controls, suggesting limited utility as a…

The director of the Division of Neuroscience at IRCCS Istituto Ortopedico Rizzoli discussed why targeting shared biologic pathways, rather than individual mutations, may represent a promising…

An Oxford study found that current smokers with MOGAD had a 2.2-times higher annualized relapse rate than never smokers, while past smokers showed no elevated risk, supporting smoking cessation as…

Ahead of the 2026 Alzheimer's Association International Conference, David Wolk, MD, discusses the meeting's biggest scientific themes, from plasma biomarkers and disease-modifying therapies to…

Roche has halted development on two of its Huntington’s disease prospects, marking another blow for a patient community that has long awaited new medicines.

GSK has walked away from a $2.2 billion biobucks neurodegenerative disease pact with Alector that has seen both “next generation” drugs involved flunk clinical trials.

Satellos Bioscience has shared evidence that its Duchenne muscular dystrophy drug candidate is active in adults, leading analysts to predict the molecule “could re-imagine the ... therapeutic…

The FDA granted Breakthrough Device Designation to NSE-FAST, the first rapid blood test to aid diagnosis of acute ischemic stroke (measuring neuron-specific enolase); a pivotal trial is planned for late 2026.

A delay in following a patient’s right kidney mass was complicated by the patient’s refusal of a CT scan and the providers’ incomplete and conflicting documentation of patient education and…

The entire care team was faulted for poor fetal monitoring — an escalation and diagnostic-focus failure that ended in a fatal outcome, a lesson in shared responsibility.

A nursing medication error compounded by missed protocols led to a patient death — how handoff gaps and system failures cascade into harm.

A 2026 review of neurology malpractice claims centered on failures in intraoperative neuromonitoring supervision and communication during spinal surgery.

Health system-led standard ACOs increased Medicare spending by 0.8% over ACO REACH’s first three years, while ACOs built around independent physician practices cut spending by the same 0.8%, a…

As SUD IMD waiver evaluations and renewals are becoming available, states face a shifting Medicaid and policy and waiver landscape. This brief examines findings from the first available summative…

As an increasing share of older adults have adopted digital health technologies over the past several years, and with most expressing interest in using them to manage their health care, the…

Vermont became the first U.S. state to ban paraquat, one of the most-used herbicides, citing a possible link to Parkinson’s disease — as the EPA continues its safety review and the manufacturer phases out production.

CMS’s proposed CY2027 Medicare Physician Fee Schedule (July 14, 2026) modernizes physician payment and shifts toward value — with a projected ~1.2–1.7% conversion-factor cut; comments close Sept 14.

Average U.S. physician pay rose about 3% to ~$386,000; eight specialties now top $500K (orthopedics leads at $611K) and ENT crossed $500K for the first time.